Key Details
Annual ROE
-32.34%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 15, 2024Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with MYMD included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
MyMD Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
MYMD
businesswire.com17 June 2024
BALTIMORE--(BUSINESS WIRE)---- $MYMD--MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases and autoimmune and inflammatory conditions, today announced the appointment of Mitchell Glass, M.D., a member of the board of directors of the Company, as president and chief medical officer. The Company also announced the appointment of Mr. Stephen Friscia, a veteran investor, to the board of.
FAQ
- What is the primary business of MyMD Pharmaceuticals?
- What is the ticker symbol for MyMD Pharmaceuticals?
- Does MyMD Pharmaceuticals pay dividends?
- What sector is MyMD Pharmaceuticals in?
- What industry is MyMD Pharmaceuticals in?
- What country is MyMD Pharmaceuticals based in?
- When did MyMD Pharmaceuticals go public?
- Is MyMD Pharmaceuticals in the S&P 500?
- Is MyMD Pharmaceuticals in the NASDAQ 100?
- Is MyMD Pharmaceuticals in the Dow Jones?
- When was MyMD Pharmaceuticals's last earnings report?
- When does MyMD Pharmaceuticals report earnings?
What is the primary business of MyMD Pharmaceuticals?
MyMD Pharmaceuticals focuses on developing innovative treatments for autoimmune and age-related diseases. The company aims to improve patient outcomes through its unique drug candidates, which target underlying causes of these conditions, offering potential solutions for unmet medical needs in the healthcare market.
What is the ticker symbol for MyMD Pharmaceuticals?
The ticker symbol for MyMD Pharmaceuticals is NASDAQ:MYMD
Does MyMD Pharmaceuticals pay dividends?
No, MyMD Pharmaceuticals does not pay dividends
What sector is MyMD Pharmaceuticals in?
MyMD Pharmaceuticals is in the Healthcare sector
What industry is MyMD Pharmaceuticals in?
MyMD Pharmaceuticals is in the Biotechnology industry
What country is MyMD Pharmaceuticals based in?
MyMD Pharmaceuticals is headquartered in United States
When did MyMD Pharmaceuticals go public?
MyMD Pharmaceuticals's initial public offering (IPO) was on 23 January 2014
Is MyMD Pharmaceuticals in the S&P 500?
No, MyMD Pharmaceuticals is not included in the S&P 500 index
Is MyMD Pharmaceuticals in the NASDAQ 100?
No, MyMD Pharmaceuticals is not included in the NASDAQ 100 index
Is MyMD Pharmaceuticals in the Dow Jones?
No, MyMD Pharmaceuticals is not included in the Dow Jones index
When was MyMD Pharmaceuticals's last earnings report?
MyMD Pharmaceuticals's most recent earnings report was on 14 August 2024
When does MyMD Pharmaceuticals report earnings?
The date for MyMD Pharmaceuticals's next earnings report has not been announced yet